Great analysis, thank you for taking the time. If Japan has a...

  1. 8 Posts.
    lightbulb Created with Sketch.  9
    Great analysis, thank you for taking the time.

    If Japan has a lower bar to pass a product to market and MSB allready has a pathway through dealings with JCR.
    What is preventing them from launching CLBP and CHF in Japan and making some money to support the time it takes to complete FDA approval in the US?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.